The 21st Century Cures Act, signed by President Obama on Dec. 13, 2016, included an array of reforms intended to streamline US FDA processes for medical devices, as well as a few incremental Medicare reforms and increased funding for precision medicine, cancer research and other activities.
It's now up to the Trump administration to implement the package. Here's where things stand as of June 19 on the implementation of key provisions for the device and diagnostics...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?